Chiropractic + Naturopathic Doctor - January/February 2022

A hairy situation

DR. ESHA SINGH, ND 2022-01-25 20:27:21

How stress impacts hair loss

If you search the term “stressed” in any internet browser, chances are you will be bombarded with images of all sorts of people pulling at their hair. While stress can manifest in many ways, there is some truth to that image – stress and hair health are deeply connected. In fact, stress, whether acute or chronic, is one of the leading causes of hair loss in adult populations around the world.

A PRIMER ON STRESS

Generally speaking, we as a society, are massively stressed out. Whether it is financial stress, relationships, work-life balance, or the fact that we are living through a pandemic, many of us are existing in an adrenaline-charged, fight-or-flight state. Whether a stressor is real or perceived, our body experiences a very real physiological response that is regulated by the HPA (hypothalamic-pituitary-adrenal) axis. This axis of communication is maintained by several critical hormones, including corticosteroid releasing factor (CRF), adrenocorticotropic hormone (ACTH) and cortisol (Lee et al, 2020).

When there is a stressor or triggering event, the hypothalamus is stimulated to produce CRF (Lee et al, 2020). CRF then acts on the CRF receptor on the anterior pituitary gland, which in turn produces proopiomelanocortin (POMC)-derived ACTH (Lee et al, 2020). Finally, ACTH acts upon the adrenal cortex to upregulate cortisol production (Lee et al, 2020). This increase in cortisol production increases glucose in the bloodstream and enhances the brain’s usage of glucose (Hoover et al, 2021). Additionally, it suppresses physiological processes that are cumbersome to the fight-or-flight state, such as digestion and reproductive processes (Hoover et al, 2021). When the stressor is removed, cortisol levels return to baseline and are maintained via negative feedback (Lee et al., 2020).

TELOGEN EFFLUVIUM

Telogen effluvium (TE) is one of the most common forms of diffuse hair loss, second only to androgenetic alopecia (Malkud et al, 2015, Asghar, 2020). The term effluvium is derived from Latin, meaning “to flow,” to infer that hair is flowing into the telogen stage (Malkud et al, 2015). It is characterized as a non-scarring form of hair loss that often presents three months after a triggering event. It can last up to six months and is self-limiting (Malkud et al., 2015).

Etiology and epidemiology

TE is a reactive process and is triggered by several stressors including metabolic stressors, hormonal shifts, lifestyle changes or certain medications (Hughes & Saleh, 2021).

TE can occur in individuals of all ages, ethnicities, and genders (Hughes & Saleh, 2021). Female patients, however, tend to experience TE more frequently than males due to more drastic hormonal changes throughout their lives (Hughes & Saleh, 2021). Female patients may also be more likely to notice and report hair shedding to their healthcare provider (Hughes & Saleh, 2021).

Anatomy and cycles

Hair is essentially made up of two structures: a shaft and a root. The shaft is what can be been on the surface of the skin, while the root is deeper down in the dermis and is surrounded by the hair follicle (informedhealth.org, 2006). The hair follicle is made up of mesenchymal-derived dermal papilla cells (DPCs) and epithelial-derived root sheets (Lee et al, 2020). The interaction between these two tissues regulates hair growth and development and maintains a normal hair cycle (Yang et al, 2010).

To understand telogen effluvium, it is important to first understand what the normal hair cycle looks like. While the hair throughout the body goes through the same stages, the duration of each stage differs depending on what part of the body you are focussing on (Hoover et al, 2021). Additionally, the rate of hair growth in individuals is influenced by many factors, including age, gender, and genetics (Hoover et al, 2021).

Skin is the largest organ of the body and up to 90% can be covered in hair follicles (Paus & Cotsarelis, 1999). The scalp portion of the skin has roughly 100,000 hair follicles and is one of the densest areas of follicles on the body (Saleh, 2021). The hair follicles undergo repetitive, regenerative cycles that consist of four stages: (1) anagen, (2) catagen, (3) telogen, and (4) kenogen (Avci, 2014). Anagen is an active stage, characterized by rapid growth. At any given time, about 90% of the hair follicles are in the anagen stage. This stage lasts between 2-6 years, with an average of three years (Saleh, 2021). During this stage, DPCs rapidly undergo mitosis, allowing for hair to grow 1/2-1 inch per month (Malkud, 2015). After anagen, the hair follicle transitions into the catagen stage. During this stage, the growth rate decelerates and the follicle prepares to go into the rest stage (Avci, 2014). This stage lasts about 10 days (Saleh, 2021). During the telogen stage, there is no growth. The follicle can stay at rest for 3-5 months (Saleh, 2021). At any given point, about 10% of hair follicles are in the telogen stage. The final stage of the hair cycle is another transitory stage, kenogen, during which the existing hair is shed and the follicle is empty (Avci, 2014). Under normal circumstances, one can lose up to 100 strands of hair per day.

Pathophysiology

In telogen effluvium, hair follicles shift prematurely into rest phase after acute or chronic stress (Asghar, 2020). Thom et al determined that stress can impact hair health and density in three main ways (Thom et al, 2016):

• Acute or chronic stress can induce hair loss

• Stress can worsen hair loss that initially caused by another condition

• Hair loss can cause increased stress due to feelings of shame and/or embarrassment

• For the purpose of this article, we will only look at acute/ chronic stress inducing hair loss.

As aforementioned, whenever there is a stressor, whether physical, psychological, or environmental, the body upregulates CRF production. Interestingly, skin has been found to contain CRF, other HPA axis hormone analogues, and their receptors, indicating that there is neuroendocrine activity at the dermal layer (Arck et al, 2006). The presence of CRF has been found to simultaneously inhibit the elongation of the hair shaft and induce the premature regression of the hair follicle (Arck et al, 2006). This is achieved by arresting the cell cycle at the G2/M phase and increasing the accumulation of reactive oxygen species (ROS) (Lee et al, 2020). High levels of CRF also inhibits the proliferation of DPC, increases the production of reactive oxygen species, decreases growth-related molecules and increases regression-related molecules (Lee et al, 2020).

Additionally, the increase of substance P, a stress-related neuropeptide, is associated with premature hair loss (Peters et al, 20006). Substance P increases mast cell degranulation, increases number of entering the late stages of catagen, and inhibits hair shaft elongation (Peters et al, 2007).

Diagnosis and differential

A thorough history and physical exam is typically enough to make a diagnosis of TE (Hughes & Saleh, 2021). The most common scenario is presented is an abrupt onset of hair shedding with little to no other symptoms. One must be diligent to question potential causative events 3-6 months prior to the onset of hair shedding(Hughes & Saleh, 2021). The clinician can opt to perform a pull test, which may or may not yield positive results. A positive test is at least 4 hairs removed with each pull (Hughes & Saleh, 2021).

If there is concern of other co-morbidities (e.g. hyperthyroidism or iron deficiency) either causing or aggravating the hair loss, further testing may be indicated (Hughes & Saleh, 2021). The differential diagnoses list can include: Alopecia Areata; Anagen Effluvium; Androgenetic Alopecia, Scarring Alopecia, Syphilis; and Trichotillomania (Hughes & Saleh, 2021).

Prognosis and treatment

TE is a self-limiting condition that typically lasts about 6 months (Peters et al, 2006). When deciding how to proceed with treatment strategies, it is key to review the patient’s history and to determine whether the initial stressor was metabolic, hormonal, lifestyle/environmental, or due to medication. If the initial stressor has either been removed or treated, there is little need to use additional therapies (Hughes & Saleh, 2021). Conventional hair growth treatments are typically not used in cases of TE, however, the patient can choose to apply topical minoxidil (Hughes & Saleh, 2015).

When treating a TE patient using the Naturopathic approach, the emphasis shifts towards supporting the adrenal glands and regulating the HPA axis. Additionally, it is imperative to review key foundational aspects of the patient’s lifestyle such as stress management/restoration techniques, reducing inflammation, improving diet and correcting

nutritional imbalances, and improving the quality of sleep. A class of herbs that is particularly useful in the treatment of TE are adaptogenic herbs. One of the best studied adaptogenic herbs is Ashwagandha, or Withania somnifera (Chandrasekhar et al, 2012). In a randomized, double-blind, placebo-controlled study, it was found that supplementing with 300 mg of Ashwagandha twice daily for 60 days significantly reduced scores on the Perceived Stress Scale, improved scores on the General Health Questionnaire-29, and Depression Anxiety Stress Scale, and reduced cortisol levels (Chandrasekhar et al, 2012). Another adaptogenic herb that may play a role in hair growth is ginseng (Choi et al, 2018). Ginseng has the potential to promote hair growth and prevent hair loss by encouraging the anagen stage while inhibiting the catagen stage (Truong et al, 2017).

An emerging treatment for hair loss, TE and otherwise, is low level laser therapy (LLLT) (Avci, et al, 2014). Low-level laser therapy stimulates cellular activity, while near-infrared laser light promotes regeneration (Avci et al, 2014). Commonly used devices have wavelengths in the 500-1100 nm range, with most evidence pointing towards 655 nm as target wavelength (Amer et al, 2021). LLLT has been found to be safe and effective in both animal studies (Avci, et al, 2014) and human studies, in both males and females (Yoon et al, 2020).

SUMMARY

Telogen effluvium is a short-term, self-limiting condition in which there is diffuse hair loss after a stressful event. The interplay between various stress hormones has been directly implicated in the condition, as they both inhibit the growth of hair and speed up the transition from growth to rest phase. Since TE is self-limiting, treatment is not necessary. If the patient, however, desires a more hands-on approach, there are various conventional and naturopathic treatment options that can target hair growth and support and restore the body’s ability to handle stress.

To view the list of references, visit cndoctor.ca/stress-hairloss

©Annex. View All Articles.

A hairy situation
https://magazine.canadianchiropractor.ca/article/A+hairy+situation/4201022/736182/article.html

Menu
  • Page View
  • Contents View
  • Advertisers
  • Website

Issue List

September/October 2022

July/August 2022

June 2022

March/April 2022

January/February 2022

November/December 2021

September/October 2021

July/August 2021

May/June 2021

March/April 2021

January-February 2021

December 2020

October 2020

September 2020

July/August 2020

June 2020

May 2020

April 2020

February 2020

December 2019

October 2019

September 2019

JulyAugust 2019

June 2019

May 2019

April 2019

February 2019

December 2018

October 2018

September 2018

July/August 2018

June 2018

May 2018

April 2018

February 2018

December 2017

October 2017

September 2017

July 2017

June 2017

May 2017

April 2017

February 2017

December 2016

October 2016

September 2016

July August 2016

June 2016

May 2016

April 2016

February 2016

December 2015

October 2015

September 2015

July August 2015

June 2015

May 2015

April 2015

February 2015

December 2014

October 2014

September 2014

July August 2014

June 2014

May 2014

April 2014

February 2014

December 2013

October 2013

September 2013

July/August 2013

June 2013

May 2013

April 2013

February 2013

December 2012

October 2012

September 2012

July/August 2012

June 2012

May 2012

February 2012

December 2011

October 2011

September 2011

July/August 2011

June 2011

May 2011

April 2011

April 2012

February 2011

December 2010

October 2010

September 2010

July/August 2010

June 2010

May 2010

April 2010

February 2010

December 2009

October 2009

September 2009

July/August 2009

June 2009

May 2009

April 2009

Febuary 2009

December 08

October 08

September 2008

July-Aug 08

June 2008

May 08

April 2008

March 20008

December 2007


Library